Alkermes plc

ALKS ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $1.48B $1.56B $1.66B $1.11B $1.17B $1.04B $1.17B $1.09B
Cost of Revenue $196.5M $245.3M $253.0M $218.1M $197.3M $178.3M $180.4M $176.4M
Gross Profit $1.28B $1.31B $1.41B $893.7M $976.4M $860.4M $990.6M $917.9M
Gross Margin 86.7% 84.2% 84.8% 80.4% 83.2% 82.8% 84.6% 83.9%
Operating Expenses
Research & Development $324.0M $245.3M $270.8M $272.7M $290.9M $394.6M $512.8M $425.4M
SG&A Expense $701.5M $645.2M $689.8M $590.8M $549.6M $538.8M $599.4M $526.4M
Operating Income $254.0M $420.6M $414.1M $-6.1M $97.7M $-112.4M $-175.5M $-99.1M
Operating Margin 17.2% 27.0% 24.9% -0.5% 8.3% -10.8% -15.0% -9.1%
Interest Expense — — $23.0M $13.0M $11.2M $8.7M $13.6M $15.4M
Pretax Income $291.5M $443.8M $421.5M $-31.1M $87.7M $-96.5M $-197.1M $-127.0M
Income Tax Expense $49.8M $71.6M $-97.6M $2.0M $11.3M $14.3M $-436.0K $12.3M
Net Income $241.7M $367.1M $355.8M $-158.3M $-48.2M $-110.9M $-196.6M $-139.3M
Net Margin 16.4% 23.6% 21.4% -14.2% -4.1% -10.7% -16.8% -12.7%
EPS (Basic) $1.47 $2.22 $2.14 $-0.97 $-0.30 $-0.70 $-1.25 $-0.90
EPS (Diluted) $1.43 $2.17 $2.10 $-0.97 $-0.29 $-0.70 $-1.25 $-0.90
Shares Outstanding (Basic) 164.7M 165.4M 166.2M 163.7M 160.9M 158.8M 157.8M 155.8M
Shares Outstanding (Diluted) 168.7M 169.2M 169.7M 163.7M 164.8M 158.8M 157.8M 155.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →